Skip to main content
. 2019 Sep 23;20(5):4415–4424. doi: 10.3892/mmr.2019.10696

Table I.

KEGG enrichment analysis results by GSEA.

Pathway name Gene number of pathway ES NES NOM P-value FDR q-value
Vascular smooth muscle contraction 110 −0.608 −1.726 0 0.188
Vibrio cholerae infection 50 0.566 1.879 0 0.119
Toll like receptor signaling 98 0.709 1.713 0 0.147
Glycosphingolipid biosynthesis lacto and neolacto series 26 0.603 1.712 0 0.119
Cytosolic DNA sensing 51 0.625 1.703 0 0.107
N-glycan biosynthesis 42 0.660 1.813 0.002 0.105
Amino sugar and nucleotide sugar metabolism 44 0.629 1.775 0.002 0.111
Leishmania infection 62 0.779 1.554 0.004 0.127
Intestinal immune network for IgA production 45 0.757 1.572 0.006 0.145
Colorectal cancer 61 0.438 1.486 0.006 0.151
Rig I like receptor signaling 65 0.536 1.675 0.008 0.119
P53 signaling 64 0.547 1.573 0.008 0.153
Chronic myeloid leukemia 72 0.392 1.504 0.008 0.167
Natural killer cell mediated cytotoxicity 129 0.635 1.621 0.010 0.127

KEGG, Kyoto Encyclopedia of Genes and Genomes; GSEA, gene set enrichment analysis; ES, enrichment score; NES, normalized enrichment score; NOM, nominal; FDR, false discovery rate.